Most of the treatment‐response ITP patients showed significantly diminished GSK‐3β+ cells in all monocytes, M1‐like monocytes and M2 monocytes, while treatment non‐response patients presented increased or slightly changed GSK‐3β+ cells (Figure 1G). The gene discussed is GSK3B; the disease is autoimmune thrombocytopenic purpura.